Employing in vitro and in vivo models, the authors established that UBE2O overexpression robustly enhances osteosarcoma cell proliferation and tumorigenesis, whereas UBE2O knockdown significantly attenuates these oncogenic processes. This evidence concerns the gene UBE2O and osteosarcoma.